Life Sciences CGL Market

offered by Hull & Company
Hull & Co has A- 8 Non Admitted market for the following...

Below are some recently written accounts our Markets - Life Sciences unit:

Type of Risk:
Herbal Raw Materials Distributor - NY
• $1,000,000 / $2,000,000
• $19,200
• $5,000
• Buybacks on Bitter Orange, Yohimbe and Willow Bark

OTC Drug Mfg. - UT
• $5,000,000 / $5,000,000
• $25,000
• $10,000
• Blanket Vendors Coverage

Sports Specific Supplements - CA
• $2,000,000 / $2,000,000
• $12,500
• $5,000
• Buybacks on Creatine and & Drinks

Pharmaceutical Contract Mfg
• $3,000,000 / $3,000,000
• $60,000
• $25,000
• Products Only; Prior Acts

What can we help you write this week?

Product Details

  • 1,000,000
  • 5,000,000
  • Unable to Disclose
  • Yes

Company Contact

Ask a Question

Availability

Available in: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY
Covered
Not Covered

Share This

Send to Friend

Contacts

Name Title Email Phone
Jeff Case Vice President jcase@hullco.com 209-507-7324

More Products